Aphria completes first shipment of medical cannabis to Shoppers Drug Mart

This information was provided by prnewswire

Send your Press Release here.

LEAMINGTON, ON, Jan. 8, 2019 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) announced today that it has completed its first shipment of medical cannabis to Shoppers Drug Mart (“SDM“).


“As the first licensed producer to partner with Shoppers Drug Mart, we are pleased to have reached this milestone,” said Vic Neufeld, Chief Executive Officer of Aphria. “This marks another important step for medical cannabis in Canada providing improved access for patients in need across the country. We are thrilled that they now have the ability to access Aphria’s renowned medical cannabis products through Shoppers Drug Mart’s newly launched ecommerce site – cannabis.shoppersdrugmart.ca.”

“The potential cannabis has for medical purposes is still largely untapped and Aphria remains committed to investing in developing new and innovative products that address unmet patient needs. For example, we will start to produce a thin, quick-dissolve strip that may provide an effective and accurate dose delivery,” added Neufeld.

The Company had previously announced a supply agreement with Shoppers Drug Mart.

We Have A Good Thing Growing

Emerald contributor since March 2012


Your email address will not be published.